Medtronic plc
Medtronic plc is a medical device company with significant political exposure through $117.6M in annual doctor payments, $50K in lobbying, and direct holdings by a former president.
BusinessWhat MDT does
Medtronic plc develops, manufactures, and sells medical devices and therapies across multiple disease areas, including cardiac and vascular, minimally invasive therapies, restorative therapies, and diabetes. Revenue is generated through the sale of implantable devices, surgical instruments, and associated consumables to hospitals and healthcare systems globally. The business is heavily dependent on physician adoption and reimbursement policies from government and private payers.
12 months past · 3 months futureMDT activity timeline
Executive Branch ConflictsMDT held by Trump-administration officials
Lifetime Government AwardsMDT federal contracts
MDT doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding MDT
Politicians Trading MDTMembers of Congress with recent MDT positions
Congressional TradesWho in Congress is trading MDT
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting MDTLive legislation impacting this stock
Political ProfileWhere MDT sits in Washington
[object Object]
STRUCTURAL: High alignment with key committee chairs (Cassidy-HELP, Capito-Approps LHHS) and a focused $50K lobbying campaign via AdvaMed. EVIDENTIARY: Zero corporate insider buys in 180 days (`get_corporate_insider_signal.total_buys`: 0), but former President Trump holds MDT stock valued up to $250K (`get_executive_branch_exposure.by_ticker[0].holdings[1].value_bucket`). Net: Strong structural access outweighs weak insider buying signal.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Heightened scrutiny of physician payments under Sunshine ActCMS"Annual doctor payments exceeding $100M documented in `get_political_influence.doctor_payments`."
Regulatory opportunities
-
Lobbying for favorable device regulation and coverageFDA, CMS"Lobbying filing for 'regulation and coverage of medical devices' via AdvaMed (`get_political_influence.lobbying_patterns[0].lobbying_amount`: $50,000)."
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
LobbyingWho's hired to advocate for MDT
Live signals + predictions for MDT — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades MDT
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord